Smart IVF is the integration of artificial intelligence (AI), time-lapse imaging and advanced data analytics into an IVF cycle — from stimulation monitoring and sperm analysis to embryo selection and patient support. Its most mature tool is AI embryo ranking, which scores embryos from thousands of images taken every 5–10 minutes — a technology whose 2024 Lancet randomised trial found no live-birth advantage, and whose accuracy is being pushed forward by foundation-model research in Nature Communications.
This guide explains which Smart IVF technologies have the strongest evidence, what they typically cost in 2026, and the exact questions to ask when comparing clinics.
What Makes IVF “Smart”?
Smart IVF is not a single product or procedure. It is a bundle of technologies that augment different stages of the cycle, and three applications are mature as of 2026.
AI embryo selection — Time-lapse incubators such as EmbryoScope, Geri and Miri photograph each embryo every 5–10 minutes from fertilization through day 5–6. AI algorithms — KIDScore, iDAScore and Life Whisperer — then analyze those thousands of images to rank embryos by implantation potential, each with a different emphasis: KIDScore has the longest track record of clinically validated morphokinetic data, iDAScore is fully automated deep-learning scoring with no manual annotation, and Life Whisperer works from static images so it applies more broadly. A review that screened 124 studies and kept 32 found most algorithms reached acceptable precision but called for standardised validation before routine use.
The 2024 Lancet TILT trial tested that promise in 1,575 couples at seven centres: live birth was 33.7% where time-lapse imaging guided both culture and embryo selection versus 33.0% under standard care, an adjusted odds ratio of 1.04 (97.5% CI 0.73–1.47) that the authors reported as not significant. In September 2024, Weill Cornell Medicine researchers published the BELA model in Nature Communications: a fully automated AI that predicts embryo chromosomal status (euploid vs. aneuploid) from time-lapse video alone, with no embryologist scoring, reaching an AUROC of 0.76 against PGT-A results. For the underlying biology, see our IVF embryo development guide.
AI sperm analysis — Machine-learning computer-assisted sperm analysis (CASA) measures sperm count, motility and morphology more accurately and repeatably than manual microscopy, cutting the variation between laboratories that makes single semen analyses hard to compare. Clinics read CASA results against the WHO 2021 lower reference limits — semen volume 1.4 mL, total motility 42%, progressive motility 30%, normal morphology 4% — and standard analysis already requires two samples after 4–5 days of abstinence, so repeatability is where CASA helps most.
Patient-facing AI navigation — Multiple clinics now offer AI chatbots and digital platforms that explain cycle steps, interpret lab results, answer questions between appointments and send personalized medication reminders. These tools are generally classified as wellness aids rather than medical devices, but they measurably reduce the administrative burden of treatment.
Two further applications — AI-selected stimulation protocols and AI prediction of ovarian hyperstimulation syndrome (OHSS) risk — are still in pilot stages with limited clinical data as of 2026.
The published evidence, not a society guideline, sets the boundary. No randomised trial has yet shown that AI scoring raises the chance of a baby, and the investigators running the next attempt say so plainly: they are launching an individual-participant-data meta-analysis in BMJ Open, 2025 because aggregate meta-analyses still show “uncertainty of benefit” while clinics keep investing in the technology. So treat AI as decision support, and ask any clinic for its own audited before-and-after numbers rather than a vendor brochure.
Smart IVF vs Traditional IVF: What Changes?
| Dimension | Traditional IVF | Smart IVF (AI-enhanced) |
|---|---|---|
| Embryo assessment | Once-daily subjective microscope grading | Continuous time-lapse imaging + objective AI scoring |
| Embryo ranking basis | Embryologist’s morphology call on the day | Thousands of data points + clinical prediction model |
| Sperm analysis | Manual microscopy, high inter-lab variability | CASA AI analysis, high reproducibility |
| Medication protocol | Standardized protocol adjusted by physician experience | Partial AI-assisted optimization (pilot stage) |
| Patient support | Phone and email | AI navigation app + personalized reminders |
| Additional cost | Baseline price | Typically $500–$5,000 extra |
| Regulatory status | Conventional medical devices | AI tools require FDA/CE clearance |
Smart IVF helps most when you (1) have several embryos and need a transfer order, (2) have repeated implantation failure needing deeper diagnosis, (3) have male factor infertility requiring objective semen data, or (4) value transparency in the lab process. If only 1–2 embryos develop, the added value of AI ranking is limited.
How Does AI Embryo Selection Work?
Embryo selection has historically been one of the most subjective steps in IVF: an embryologist takes embryos out of the incubator once a day, grades them under a microscope and sends them back. Time-lapse AI reverses that workflow — embryos stay undisturbed in the incubator from day 1 through day 5 or 6 while a built-in camera photographs them every 5–10 minutes, generating thousands of data points per embryo.
The AI then analyzes morphokinetic parameters — exact division timing, multinucleation, fragmentation patterns and blastocyst expansion dynamics — that correlate with implantation success.
A July 2025 Nature Communications study trained a foundation model called FEMI on about 18 million time-lapse embryo images and outperformed existing benchmarks in ploidy prediction (AUROC above 0.75), blastocyst quality scoring, segmentation and developmental timing. The training corpus is the caveat: roughly 98% of those images came from Weill Cornell Medicine and IVF Florida, while public datasets from Nantes, Spain and other European clinics made up about 1%.
The limits matter as much as the capability. AI improves the accuracy of embryo ranking, but it does not change an embryo’s biology — a clinic’s overall embryology quality, lab protocols and culture conditions still matter far more than whether AI scoring is switched on.
“While not a replacement for preimplantation genetic testing for aneuploidy, BELA exemplifies how such models can streamline the embryo evaluation process.” — Rajendran S, et al., Nature Communications, 2024
Does Smart IVF Cost More?
Yes — the technologies add to the bill, and pricing varies widely by clinic and country:
| Technology | United States | Thailand | United Kingdom |
|---|---|---|---|
| Time-lapse incubator (in-cycle) | $500–$1,500 | ฿15,000–฿50,000 | £500–£1,200 |
| AI embryo scoring (with time-lapse) | Usually bundled into the time-lapse fee | Bundled | Usually bundled |
| AI sperm analysis (CASA) | $100–$300 | ฿3,000–฿8,000 | £80–£200 |
| AI patient navigation app | Free–$200 per cycle | Free–฿6,000 | Free–£150 |
ProIVF editorial compilation from published clinic price pages and public cycle quotes, not a verified market survey — confirm figures in writing before booking.
Some clinics bundle these features into a premium “AI-enhanced” cycle priced $2,000–$5,000 above a standard cycle. The premium makes most sense for patients with several good-quality embryos who need a defensible transfer order; for others, the same money may be better spent on lab quality itself.
What Do Patients Say?
Patient stories are shared with consent; names and identifying details have been changed.
Emma, 36, London — two failed cycles before switching to a time-lapse AI clinic. “Both times the clinic said the embryos ‘looked good’ and neither implanted, and nobody could tell me why. I switched to a clinic using EmbryoScope with KIDScore, and the embryologist showed me the time-lapse video of each embryo. You could literally see irregular division at the 4-cell stage that a daily 10-second check would never catch. The AI ranked the embryos completely differently from the previous clinic’s manual grading, and the top-ranked one on the new list worked. I’m 28 weeks pregnant now. Was it the AI or the better lab? I honestly don’t know — but the transparency alone was worth it.”
Carlos and Mei, 42, Bangkok — choosing AI-assisted IVF abroad. “We came to Bangkok because the cost was half of Australia’s. Our clinic uses the Geri time-lapse system with AI scoring. We grew 6 blastocysts, the AI ranked them by implantation potential, and the top-ranked one gave us our daughter. The whole cycle cost about $10,000 with medication versus $25,000+ at home. The ranking gave us the confidence to transfer a single embryo — no twin risk, no storage fees for spares.”
Sarah, 39, New York — AI sperm analysis found the hidden male factor. “My husband’s semen analyses at two different labs contradicted each other — one normal, one borderline. Our clinic ran a CASA AI system that measured over 2,000 sperm per sample, and morphology was consistently low in a way manual microscopy had missed. We moved to ICSI with sperm DNA fragmentation testing, and the embryologist used AI-guided morphology to select sperm with better chromatin integrity. One cycle produced 3 euploid embryos — our best result ever. Without that analysis we’d still be doing failed rounds and blaming the wrong person.”
FAQ
Q: Does AI guarantee a successful IVF cycle?
No — AI improves embryo ranking from the thousands of images captured every 5–10 minutes, but cannot change embryo biology, uterine receptivity or cycle management.
Success still depends on egg quality, sperm quality, lab conditions and your own health — AI is decision support, not a cure.
Q: How much does Smart IVF increase success rates?
No randomised trial has yet demonstrated a live-birth gain. In the 2024 Lancet TILT trial, live birth was 33.7% with time-lapse imaging for culture plus embryo selection and 33.0% with standard care (adjusted OR 1.04, 97.5% CI 0.73–1.47), while time-lapse imaging for undisturbed culture alone reached 36.6% (adjusted OR 1.20, 0.85–1.70).
What AI does change is consistency: models such as BELA score every embryo the same way, with no embryologist annotation, at AUROC 0.76 for ploidy. Our IVF success rate guide explains how to read clinic numbers.
Q: Is every clinic with a time-lapse incubator using AI?
No — many clinics buy time-lapse incubators for the stable culture environment (the camera photographs embryos every 5–10 minutes regardless) but never license the AI scoring module.
Ask specifically whether they run KIDScore, iDAScore or Life Whisperer, and what outcome improvement they have measured in their own cycles.
Q: Are Smart IVF technologies regulated?
Increasingly, yes: embryo-selection AI is regulated as medical-device software — by the FDA in the US, under the EU Medical Device Regulation for CE marking, and by the UK’s MHRA. Ask which of these clearances the tool at your clinic actually holds, because marketing pages rarely say.
Patient-facing navigation apps remain lightly regulated wellness tools. You have the right to ask whether a clinic’s AI has clearance in your country.
Q: Does Smart IVF reduce the risk of twins?
Indirectly, yes: higher confidence in embryo ranking supports elective single embryo transfer (eSET) — putting back 1 instead of 2 — which sharply cuts the risk of twins, triplets, preterm birth and low birth weight.
For many patients this is the technology’s most valuable real-world effect.
Q: Can Smart IVF help with recurrent implantation failure?
Potentially: AI can re-analyze thousands of stored time-lapse images from previous failed cycles and surface abnormalities conventional grading missed — irregular division at the 4-cell stage, multinucleation, fragmentation patterns — which can steer the next cycle toward PGT-A or a different protocol.
Our repeated implantation failure guide covers the full diagnostic pathway.
Q: Is Smart IVF available everywhere?
Time-lapse and AI tools are most common in the US, UK, Western Europe, Australia, Thailand and parts of the Middle East, with patchy availability elsewhere. That geography also limits the evidence: the authors of the FEMI foundation model state that data “predominantly sourced from high-resource settings … may not capture the variability found in lower-resource environments.” A model validated mostly in two US clinics is not automatically valid in yours.
How Do You Choose a Smart IVF Clinic?
Ask questions that separate genuine capability from marketing:
- Do you use time-lapse incubators, and which brand? EmbryoScope, Geri and Miri are the common platforms.
- Do you run AI embryo scoring, and which model? KIDScore, iDAScore and Life Whisperer have published validation data.
- How much weight does the AI score carry in transfer decisions? It should supplement embryologist judgment, not silently replace it.
- What outcome improvement have you measured with the AI you use? Ask for clinical data, not brochures.
- Is your AI tool cleared as a medical device? In the US that means FDA 510(k); in the EU, CE marking.
- Is sperm analysis CASA-based or manual microscopy? Consistent objective sperm data matters, especially for male factor cases.
- What is the all-in cost of an AI-enhanced cycle vs a standard cycle? Get an itemized quote, including the $500–$5,000 technology add-ons.
A quick maturity ladder: Basic = time-lapse incubator, no AI software; Intermediate = time-lapse + AI scoring (KIDScore/iDAScore) used as a reference; Advanced = AI systematically integrated with embryologist assessment plus published internal validation; Leading = next-generation foundation models and participation in AI research. Aim for at least Intermediate. Our guide on how to choose an IVF clinic covers the rest of the evaluation framework, and browsing the ProIVF hospital directory shows which listed centers advertise time-lapse and AI options alongside verified success rates and patient reviews.
What Is the Future of Smart IVF?
Three directions are already visible. The 18-million-image foundation model published in Nature Communications in July 2025 points toward standardised embryo assessment across tasks rather than clinic-specific add-ons.
Non-invasive ploidy prediction from imaging could reduce how often PGT-A biopsy is needed: the STORK-A model reported in The Lancet Digital Health classified aneuploid versus euploid blastocysts at 69.3% accuracy (AUC 0.761) across 10,378 biopsied embryos, and, on a reduced input set, held 63.4–65.7% accuracy across two independent external datasets. Treat that as a triage aid, not a test result — see our PGT-A genetic screening guide for what biopsy still provides today. AI-driven stimulation optimisation, still in pilots, may eventually tailor medication to individual biomarkers.
What will not change is the embryologist’s role. Every credible forecast describes AI as augmenting rather than replacing human expertise, and the best outcomes will come from labs where skilled embryologists work alongside validated tools.
References
- Bhide P, Chan DYL, Lanz D, et al. “Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial.” The Lancet, 2024, 404(10449):256-265. DOI: 10.1016/S0140-6736(24)00816-X PMID: 39033010
- Rajendran S, Brendel M, Barnes J, Zhan Y, et al. “Automatic ploidy prediction and quality assessment of human blastocysts using time-lapse imaging.” Nature Communications, 2024, 15(1):7756. DOI: 10.1038/s41467-024-51823-7 PMID: 39237547
- Rajendran S, Rehani E, Phu W, Zhan Q, et al. “A foundational model for in vitro fertilization trained on 18 million time-lapse images.” Nature Communications, 2025, 16(1):6235. DOI: 10.1038/s41467-025-61116-2 PMID: 40645954
- Barnes J, Brendel M, Gao VR, Rajendran S, et al. “A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: a retrospective model development and validation study.” The Lancet Digital Health, 2023, 5(1):e28-e40. DOI: 10.1016/S2589-7500(22)00213-8 PMID: 36543475
- Bhide P, Chan DYL, Ahlström A, et al. “Time-lapse imaging systems for embryo incubation and assessment to improve reproductive outcomes in women undergoing in vitro fertilisation: study protocol for an individual participant data meta-analysis of randomised controlled trials.” BMJ Open, 2025, 15(7):e101761. DOI: 10.1136/bmjopen-2025-101761 PMID: 40730404
- Fernandez EI, Ferreira AS, Cecílio M, et al. “Artificial intelligence in the IVF laboratory: overview through the application of different types of algorithms for the classification of reproductive data.” Journal of Assisted Reproduction and Genetics, 2020, 37(10):2359-2376. DOI: 10.1007/s10815-020-01881-9 PMID: 32654105
This article was written by the ProIVF Medical Editorial Team and reviewed by the ProIVF Medical Advisory Board. It is based on six peer-reviewed sources published 2020–2025 in The Lancet, The Lancet Digital Health, Nature Communications, BMJ Open and the Journal of Assisted Reproduction and Genetics, and every trial figure here is taken from that trial’s own published report — stated limitations are quoted, not paraphrased away.
Smart IVF technologies and their availability vary by clinic and region; verify pricing, regulatory status and clinical evidence directly with any clinic before making treatment decisions.
Last updated: July 15, 2026. This article is for informational purposes only and does not constitute medical advice. Consult a qualified reproductive specialist for personalized guidance, or contact the ProIVF team for help comparing clinics.
